Skip to main content
Global Bioenergies logo

Global Bioenergies — Investor Relations & Filings

Ticker · ALGBE ISIN · FR0011052257 LEI · 969500H46XRAMTMVB676 PA Manufacturing
Open in API
Filings indexed 443 across all filing types
Latest filing 2017-12-12 Regulatory Filings
Country FR France
Listing PA ALGBE

About Global Bioenergies

https://www.global-bioenergies.com/?lan…

Global Bioenergies develops and commercializes a process to convert renewable resources, such as plant-based sugars and agricultural waste, into isobutene. The company's proprietary technology utilizes fermentation and synthetic biology to produce this key hydrocarbon, which serves as a platform molecule for various applications. The bio-isobutene can be converted into ingredients for the cosmetics industry, specialty chemicals, and renewable fuels. A primary strategic focus is the production of Sustainable Aviation Fuel (SAF) to support the decarbonization of the aviation sector. The process provides a bio-based alternative to petroleum-derived hydrocarbons, aiming to reduce CO2 emissions and dependence on fossil fuels.

Recent filings

Filing Released Lang Actions
GLOBAL BIOENERGIES PRESS RELEASE
Regulatory Filings Classification · 95% confidence The document is a press release dated December 12, 2017, announcing a specific operational update: the start of the scale-up phase for a new process to convert renewable resources into acetone and isopropanol. It details technical progress, mentions key partners (ARD), and includes quotes from management. This type of announcement, focusing on business development, operational milestones, and strategic progress rather than formal financial results (like 10-K or ER) or mandatory regulatory filings, fits best under a general announcement category. Since it is not a formal financial report, a management discussion (MDA), or a specific capital event (CAP), it is best classified as a general Regulatory Filing (RNS) as it is a public announcement of a significant business event, or potentially an Investor Presentation (IP) if it were structured as slides, but given the press release format, RNS is the most appropriate fallback for non-standard, material news.
2017-12-12 English
GLOBAL BIOENERGIES COMMUNIQUE DE PRESSE
Regulatory Filings Classification · 95% confidence The document is a press release dated December 12, 2017, announcing that Global Bioenergies has initiated the scale-up phase for a second process to convert renewable resources into acetone and isopropanol. It details technological progress, partnerships (ARD, Cristal Union), and future plans. This type of announcement, focusing on operational progress, technology development, and strategic updates outside of mandatory periodic financial reporting (like 10-K or IR), is best classified as a general corporate announcement. Since it is not a formal earnings release (ER), a capital change (CAP/SHA), a management change (MANG), or a specific regulatory filing like DIRS or DIV, it falls under the general category for corporate news that doesn't fit elsewhere, which is Regulatory Filings (RNS) as per the provided definitions, or potentially an Investor Presentation (IP) if it were structured as slides, but here it reads like a news update. Given the content is a specific operational update and announcement, RNS serves as the most appropriate general regulatory/corporate news category when specific categories like ER or MANG do not apply. The length (4872 chars) is substantial enough to be the primary document, not just a link announcement (RPA).
2017-12-12 French
GLOBAL BIOENERGIES - PRESS RELEASE
Regulatory Filings Classification · 95% confidence The document is a press release dated November 27, 2017, announcing the delivery of a first batch of sustainable cosmetic ingredients to L'Oréal, produced under the ISOPROD project. It details a specific business development, a product milestone, and includes quotes from the CEO and contact information. This type of announcement, focusing on a specific operational or strategic update that isn't a standard financial report (like 10-K, ER, or IR), fits best under the general 'Regulatory Filings' category (RNS) as a miscellaneous corporate announcement, or potentially a specialized announcement if one existed. Since it is not a formal financial report, a management change, a dividend notice, or a capital event, and it is not explicitly announcing the publication of another report (RPA), RNS serves as the most appropriate general regulatory announcement fallback. Given the content is a specific business update/achievement, RNS is the best fit among the provided options.
2017-11-27 English
GLOBAL BIOENERGIES - COMMUNIQUE DE PRESSE
Regulatory Filings Classification · 95% confidence The document is a press release dated November 27, 2017, announcing that Global Bioenergies delivered a first batch of renewable cosmetic ingredient to L'Oréal under the ISOPROD project. It details a specific business transaction and development milestone, concluding with contact information and boilerplate 'About Us' sections. This type of announcement, detailing a specific operational event or partnership update that is not a mandatory periodic financial filing (like 10-K or IR) or a standard earnings release (ER), fits best under the general 'Regulatory Filings' (RNS) category, as it is a material, non-financial corporate announcement. It is too specific for a general 'Capital/Financing Update' (CAP) and does not relate to management changes (MANG), dividends (DIV), or legal matters (LTR). Given the options, RNS serves as the appropriate catch-all for significant, non-standard corporate news releases.
2017-11-27 French
GLOBAL BIOENERGIES PRESS RELEASE
Board/Management Information Classification · 99% confidence The document text is an announcement titled "Global Bioenergies strengthens its management team" detailing the appointments of Luc Mathis as Chief Business Officer and Samuel Dubruque as Chief Financial Officer, along with a change in leadership for the German subsidiary. This content directly relates to changes in senior management personnel. According to the definitions, this aligns perfectly with the Board/Management Information category (MANG). The document is not a full annual report (10-K), an earnings release (ER), or a proxy statement (DEF 14A/PSI).
2017-10-03 English
GLOBAL BIOENERGIES COMMUNIQUE DE PRESSE
Board/Management Information Classification · 98% confidence The document text is a press release announcing significant changes in the company's senior management team, specifically naming a new Chief Business Officer, a new Chief Financial Officer, and a new Director of Engineering for the German subsidiary. This content directly aligns with the definition of 'Board/Management Information' (MANG), which covers announcements of changes in the company's board of directors or senior management.
2017-10-03 French

Browse filings by year

13 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.